Isabella Borges

Isabella Borges focuses her practice on general corporate matters, including formation, corporate governance, mergers and acquisitions, and venture capital transactions.

Isabella advises startup companies and investors across a variety of industries through all stages of their life cycle, including formation, venture capital financings and growth equity investments. She also advises both strategic acquirers and target companies in their mergers and acquisitions, joint ventures and other transactional matters. In addition, Isabella also assists public companies in their public and other equity offerings.

Representative Experience

Represented HealthQuest Capital in leading a $142 million equity financing for OrganOx Ltd.
Represented Clearwater Paper Corporation in the sale of its tissue business to Sofidel America Corporation, a subsidiary of Sofidel S.p.A., for $1.06 billion.
Represented Hasura in its $100 million Series C funding round.

Representative Emerging Growth Financings
- Represented HealthQuest Capital in leading a minority growth equity investment for Cellipont Bioservices.
- Represented Red Arrow Therapeutics in its $4.5 million Series Seed extension round.
- Represented AT&T Ventures in its investment in Unruly Studios.
- Represented Disa Technologies in its $15 million Series A funding round.
- Represented PowerPlant Partners in leading a $35 million Series C funding round for Bobbie.
- Represented Cloverly in its $19 million Series A funding round.
- Represented WeTravel in its $27 million Series B funding round.

Representative Mergers & Acquisitions Transactions
- Represented Clearwater Paper Corporation in its acquisition of an Augusta, Georgia-based bleached paperboard manufacturing facility from Graphic Packaging Holding Company, for approximately $700 million.
- Represented Lithium Power International Ltd (LPI) in its acquisition of an approximate 30 percent joint venture interest in the Maricunga Lithium Brine Project in Chile (Maricunga) from Minera Salar Blanco SpA (Minera).
- Represented HealthQuest Capital in connection with Epilog Partners’ acquisition of Care Connectors Medical Group, which included a co-investment by HealthQuest.

Representative Capital Markets Experience
- Represented Nikola Corporation in its $100 million convertible note exchange.

Education

J.D., Golden Gate University School of Law, 2021
Graduated First in Class

B.A., Communications, University of Colorado, Boulder, 2017
Minor in Business

Admissions

California

Areas of Focus

Practices

Representative Experience

Isabella's Insights